Concord CA 肥胖症临床试验
18项针对 肥胖症的研究正在 Concord及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- John Muir Health - Concord /ID# 282469, Concord
- Diablo Clinical Research /ID# 282530, Walnut Creek · 距离 5 英里
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
招募中3 期
- Diablo Clinical Research, Inc., Walnut Creek · 距离 5 英里
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
招募中2 期
- Diablo Clinical Research - Flourish Research, Walnut Creek · 距离 5 英里
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
招募中3 期
- Diablo Clinical Research, Inc., Walnut Creek · 距离 5 英里
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
招募中3 期
- Diablo Clinical Research, Inc., Walnut Creek · 距离 5 英里
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Walnut Creek · 距离 5 英里
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- Diablo Clinical Research, Inc., Walnut Creek · 距离 5 英里
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, Walnut Creek · 距离 5 英里
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- Diablo Clinical Research, Walnut Creek · 距离 5 英里
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
招募中3 期
- Diablo Clinical Research, Inc., Walnut Creek · 距离 5 英里
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
招募中2 期
- Diablo Clinical Research, Inc., Walnut Creek · 距离 5 英里
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
招募中3 期
- Diablo Clinical Research, Inc., Walnut Creek · 距离 5 英里
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
招募中2 期
- Diablo Clinical Research, Inc., Walnut Creek · 距离 5 英里
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
招募中3 期
- Diablo Clinical Research, Walnut Creek · 距离 5 英里
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- John Muir Physicians Network, Concord
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
招募中2 期
- Diablo Clinical Research - Flourish Research, Walnut Creek · 距离 5 英里
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
招募中3 期
- Diablo Clinical Research, Inc., Walnut Creek · 距离 5 英里
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
招募中1 期
- Diablo Clinical Research, Inc., Walnut Creek · 距离 5 英里
其他城市的 肥胖症试验
- Houston, TX43 项研究
- Chicago, IL41 项研究
- New York City, NY40 项研究
- San Antonio, TX40 项研究
- Washington, DC33 项研究
- Orlando, FL31 项研究
- Dallas, TX30 项研究
- Boston, MA28 项研究
- Las Vegas, NV27 项研究
- Miami, FL27 项研究
- Baltimore, MD25 项研究
- Jacksonville, FL25 项研究
Concord的其他研究
- 超重16 项研究
- 非小细胞肺癌14 项研究
- 重度抑郁症12 项研究
- 2型糖尿病10 项研究
- 肺癌9 项研究
- 乳腺癌9 项研究
- 偏头痛8 项研究
- 癌症（所有类型）7 项研究
- 前列腺癌6 项研究
- 抑郁症6 项研究
- 高血压5 项研究
- 糖尿病5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。